The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Staging of brain pathology related to sporadic Parkinson’s disease
Abstract
Sporadic Parkinson's disease involves multiple neuronal systems and results from changes developing in a few susceptible types of nerve cells. Essential for neuropathological diagnosis are alpha-synuclein-immunopositive Lewy neurites and Lewy bodies. The pathological process targets specific induction sites: lesions initially occur in the dorsal motor nucleus of the glossopharyngeal and vagal nerves and anterior olfactory nucleus. Thereafter, less vulnerable nuclear grays and cortical areas gradually become affected. The disease process in the brain stem pursues an ascending course with little interindividual variation. The pathology in the anterior olfactory nucleus makes fewer incursions into related areas than that developing in the brain stem. Cortical involvement ensues, beginning with the anteromedial temporal mesocortex. From there, the neocortex succumbs, commencing with high order sensory association and prefrontal areas. First order sensory association/premotor areas and primary sensory/motor fields then follow suit. This study traces the course of the pathology in incidental and symptomatic Parkinson cases proposing a staging procedure based upon the readily recognizable topographical extent of the lesions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, although α-syn appears early in peripheral tissues, brain damage in PD begins in the brainstem and spreads to the cortex [125,133,134,135].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [125]
In the citing paper
“The current understanding of PD pathogenesis suggests that a combination of genetic and environmental factors contributes to the progressive neurodegeneration of nigrostriatal dopaminergic neurons in the pars compacta of the substantia nigra, as well as other affected cortical regions [125,126].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [125]
In the citing paper
“robust evidence suggests that PD could start in the ENS and spread from there to the CNS via the vagal nerve [222,223].”
From Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis (2020) · cites this paper as [222]
In the citing paper
“Braak et al. (2003) have mapped PD into six neuropathological disease stages.”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Braak et al. 2003
In the citing paper
“Early research on the neural mechanisms of anxiety in PD suggests that cingulate cortex alterations, associated with interoception deficit, could be a key point of anxiety pathophysiology and treatment24,25.”
From The experience of Anxiety for people with Parkinson’s disease (2023) · cites this paper as [24]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“The severity of co-occurring AD-related pathology was classified according to a procedure permitting differentiation of stages I–VI in the development of neurofibrillary changes and stages A–C in the evolution of -amyloid deposits (Table 2) [6,48].”
MethodSelf-citationParkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107 · cited 1×
“A: age, G: gender, nfp: neurofibrillary pathology, stages I–VI, a : stages of cortical –amyloid deposition A–C (0 = no AD-related lesions), PD: PD stages 1–6, clin: clinical diagnoses (−, no mention of PD symptoms in the clinical protocols, PD I–V: clinically diagnosed cases are indicated by PD and—if available—the Ho…”
BackgroundSome Methods for Strengthening the Common χ 2 Tests
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001616 · Cited by 3,718
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822 · cited 1×
“The brain tissue exhibited nigral LBs and severe loss of nigral neuromelanin-laden neurons [16,30,37,62] (Fig.”
BackgroundThe substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,756 · cited 2×
“Damage to specific subnuclei of the substantia nigra, pars compacta, with severe obliteration of their neuromelaninladen projection neurons, frequently is considered to be the most important hallmark of PD [ 20 ,31,38,39,43].”
BackgroundResultFrequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656 · cited 1×
“The concomitant AD-related pathology lies within the expected range of the respective age groups [ 9 ].”
BackgroundSelf-citation(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Paxinos, G., & Jürgen, K. (2004) · Cited by 1,478
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465 · cited 1×
“A prerequisite for the postmortem diagnosis of both the presymptomatic and symptomatic phases of the pathological process underlying PD is evidence of specific inclusion bodies, which develop as spindle- or thread-like Lewy neurites (LNs) in cellular processes, and in the form of globular Lewy bodies (LBs) in neuronal…”
BackgroundCognitive deficits in Parkinson’s disease
Dubois, B., & Pillon, B. (1996) · Journal of Neurology · doi:10.1007/pl00007725 · Cited by 903 · cited 1×
“The damage incurred by important limbic structures (amygdala, hippocampal formation, anteromedial temporal mesocortex) as well as by extensive neocortical territories during stages 5–6 might well be considered to pave the way for declining intellectual faculties [14] and, in fact, impaired cognition is a frequent phen…”
Background
Research works printed but not linked: 7
- Braak H. Architectonics as seen by lipofuscin stains. In: Jones EG, Peters A, editors. Cerebral cortex. Cellular components of the cerebral cortex, vol. 1. London: Plenum Press, 1984. p. 59–104.
- Braak H, Braak E, Yilmazer D, Schultz C, Bohl J. Age-related changes of the human cerebral cortex. In: Cruz-Sanchez FF, Ravid R, Cuzner ML, editors. Neuropathological diagnostic criteria for brain banking. Biomedical health research, vol. 10. Amsterdam: IOS Press 1995;19:14–9.
- Fearnley J, Lees AJ. Pathology of Parkinson’s disease. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: Saunders, 1991. p. 545–54.
- Hassler, 1937, Zur Normalanatomie der Substantia nigra. Versuch einer architektonischen Gliederung, J. Psychol. Neurol., 48, 1
- Hassler, 1938, Zur Pathologie der paralysis agitans und des postencephalitischen Parkinsonismus, J. Psychol. Neurol., 48, 387
- Lowe J. Lewy bodies. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: Saunders, 1994. p. 51–69.
- Rajput AH. Clinical features and natural history of Parkinson’s disease (special consideration of aging). In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: Saunders, 1994. p. 555–71.
Cited by
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Bloem, B. R., Okun, M. S., & Klein, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00218-x · Cited by 3,920
Metadata
- Authors
- Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Braak, Heiko
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 24
- Issue
- 2
- Pages
- 197-211
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2073449985
- Cited by
- 10,777
- References
- 71
- Citations by year
- 2026: 569 · 2025: 700 · 2024: 735 · 2023: 626 · 2022: 749 · 2021: 731 · 2020: 724 · 2019: 594 · 2018: 547 · 2017: 551 · 2016: 475 · 2015: 493 · 2014: 450 · 2013: 485 · 2012: 403
- FWCI
- 45.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, neuropathology, alpha-synuclein, Lewy bodies, Lewy neurites, dorsal motor nucleus of the vagus, anterior olfactory nucleus, brainstem, cortical involvement, prefrontal cortex, neuropathological diagnosis
- MeSH terms
- Aged, Aged, 80 and over, Brain, Female, Humans, Male, Medulla Oblongata, Parkinson Disease, Temporal Lobe, Lewy Bodies, Neocortex, Lewy Body Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Staging of brain pathology related to sporadic Parkinson’s disease. https://app.cochat.ai/papers/10.1016/s0197-4580(02)00065-9
- The paper
- Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging. https://doi.org/10.1016/s0197-4580(02)00065-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.